DISCERNDX INC has a total of 24 patent applications. It increased the IP activity by 75.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets computer technology, measurement and chemical engineering are HAEMOSCOPE CORP, NOVACYT and VETERINARY DIAGNOSTICS INST INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | China | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Measurement | |
#3 | Chemical engineering | |
#4 | Foods and drinks | |
#5 | Biotechnology | |
#6 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Wilcox Bruce | 19 |
#2 | Jones Jeffrey | 16 |
#3 | Benz Ryan | 16 |
#4 | Croner Lisa | 16 |
#5 | Blume John | 15 |
#6 | You Jia | 12 |
#7 | Kao Athit | 10 |
#8 | Dillon Roslyn | 7 |
#9 | Smith William | 6 |
#10 | Schreckengaust Scott | 4 |
Publication | Filing date | Title |
---|---|---|
CN111684282A | Robust panel of colorectal cancer biomarkers | |
US2021063410A1 | Automated sample workflow gating and data analysis | |
EP3678779A1 | Marker analysis for quality control and disease detection | |
WO2018232043A1 | Tandem identification engine | |
CN110596385A | Methods for assessing the presence or risk of a colon tumor |